Guangyi Yu
Biographic Data
| ID | 10023583 |
|---|---|
| NAME | Guangyi Yu |
| GIVEN NAMES | Guangyi |
| FAMILY NAME | Yu |
| SIGNATURE | YU G |
| AFFILIATIONS | Wuhan Dongxihu District People Hospital |
| ORCID | 0000-0002-1123-1723 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
Objective: We aimed to assess the cost-effectiveness of sequential teriparatide/zoledronic acid relative to zoledronic acid monotherapy for postmenopausal osteoporotic women in China. Methods: A previously validated Markov microsimulation model was updated to examine the cost-effectiveness of daily subcutaneous teriparatide for 2 years followed by annual intravenous zoledronic acid for 3 years (sequential teriparatide/zoledronic acid), compared w…
No prominent works on this page.
Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
Objective: We aimed to assess the cost-effectiveness of sequential teriparatide/zoledronic acid relative to zoledronic acid monotherapy for postmenopausal osteoporotic women in China. Methods: A previously validated Markov microsimulation model was updated to examine the cost-effectiveness of daily subcutaneous teriparatide for 2 years followed by annual intravenous zoledronic acid for 3 years (sequential teriparatide/zoledronic acid), compared w…
Bone health and osteoporosis research (1 work) · Bone health and treatments (1 work) · Bone Metabolism and Diseases (1 work) · Bone mineral (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Osteoporosis (1 work) · Teriparatide (1 work) · Zoledronic acid (1 work)